Cannabis Science, Inc. (CBIS)
-OTC Markets 0.05 
0.00(3.09%) May 17, 3:59PM EDT
| Prev Close: | 0.05 |
|---|
| Open: | 0.05 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 5.68 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.05 - 0.05 |
|---|
| 52wk Range: | 0.03 - 0.12 |
|---|
| Volume: | 1,147,935 |
|---|
| Avg Vol (3m): | 6,745,860 |
|---|
| Market Cap: | 32.16M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.03 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Being On The Frontier Of Marijuana Prohibition Is Tough Businessat Seeking Alpha(Mon, May 13)
- Intro To Pot Stocks: Plenty Of Risks Mixed With Large Potential Rewardsat Seeking Alpha(Tue, May 7)
- CANNABIS SCIENCE, INC. FinancialsEDGAR Online Financials(Fri, Apr 26)
- Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterizationPR Newswire(Fri, Apr 26)
- CANNABIS SCIENCE, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 22)
- Marijuana Bubble: Don't Inhaleat Seeking Alpha(Sun, Apr 21)
- Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18PR Newswire(Tue, Apr 16)
- Marijuana Stocks Are Extremely Dangerous Investmentsat Seeking Alpha(Sun, Apr 14)
- Marijuana Stocks Could Be Setting Up For A Nice Short Squeezeat Seeking Alpha(Tue, Apr 9)
- Who Will Own the Marijuana Industry If Weed Is Legalized?at Wall St. Cheat Sheet(Mon, Apr 8)
- The Original Marijuana Stock Files For U.S. IPOat Seeking Alpha(Mon, Apr 1)
- Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus Pharmaceuticals, to the Company's Scientific AdPR Newswire(Wed, Mar 27)
- Cannabis Science Masters The Art Of Shareholder Dilutionat Seeking Alpha(Mon, Mar 11)
- Barbarians At The Gates Of The U.S. Medical Marijuana Marketat Seeking Alpha(Thu, Feb 28)
- Cannabis Science Appoints Richard Ogden, PhD, Former Director of Scientific Affairs, HIV, Pfizer, as Chief Scientific OfficerPR Newswire(Wed, Feb 27)
Press Releases
- Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterizationPR Newswire(Fri, Apr 26)
- Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18PR Newswire(Tue, Apr 16)
- Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus Pharmaceuticals, to the Company's Scientific AdPR Newswire(Wed, Mar 27)
Reports
- No Reports available for CBIS at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 907.40 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.
View More